An evaluation of the effect of an angiotensinconverting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: A randomized placebo-controlled trial (AARDVARK)

on behalf of the Aardvark Collaborators

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Abstract

Aims: The AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) trial investigated whether ACE-inhibition reduces small abdominal aortic aneurysms (AAA) growth rate, independent of blood pressure (BP) lowering. Methods and results: A three-arm, multi-centre, single-blind, and randomized controlled trial (ISRCTN51383267) was conducted in 14 hospitals in England. Subjects aged ≥55 years with AAA diameter 3.0-5.4 cm were randomized 1:1:1 to receive perindopril arginine 10 mg, or amlodipine 5 mg, or placebo and followed 3-6 monthly over 2 years. The primary outcome was aneurysm growth rate (based on external antero-posterior ultrasound measurements in the longitudinal plane), determined by multi-level modelling to provide maximum likelihood estimates. Two hundred and twenty-four subjects were randomized (2011-2013) to placebo (n = 79), perindopril (n = 73), or amlodipine (n = 72). Mean (SD) changes in mid-trial systolic BP (12 months) were 0.5 (14.3) mmHg, P = 0.78 compared with baseline, 29.5 (13.1) mmHg (P < 0.001), and 26.7 (12.0) mmHg (P < 0.001), respectively. No significant differences in the modelled annual growth rates were apparent [1.68 mm (SE 0.2), 1.77 mm (0.2), and 1.81 mm (0.2), respectively]. The estimated difference in annual growth between the perindopril and placebo groups was 0.08 mm (CI 20.50, 0.65). Similar numbers of AAAs in each group reached 5.5 cm diameter and/or underwent elective surgery: 11 receiving placebo, 10 perindopril, and 11 amlodipine. Conclusion: Small AAA growth rates were lower than anticipated, but there was no significant impact of perindopril compared with placebo or placebo and amlodipine, combined despite more effective BP lowering.

Original languageEnglish
Pages (from-to)3213-3221
Number of pages9
JournalEuropean Heart Journal
Volume37
Issue number42
DOIs
Publication statusPublished - 7 Nov 2016

Bibliographical note

Publisher Copyright:
© The Author 2016.

Keywords

  • ACE-inhibition
  • Abdominal aortic aneurysm
  • Blood pressure lowering
  • Calcium channel blocker
  • Perindopril
  • Placebo-controlled

Fingerprint

Dive into the research topics of 'An evaluation of the effect of an angiotensinconverting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: A randomized placebo-controlled trial (AARDVARK)'. Together they form a unique fingerprint.

Cite this